Strategies and advances in laboratory tests for primary liver cancer
10.3760/cma.j.cn112150-20230412-00288
- VernacularTitle:原发性肝癌实验室检查策略及进展
- Author:
Yuan CHEN
1
;
Jing LIANG
;
Yunhui LI
;
Yajie WANG
Author Information
1. 北京大学地坛医院教学医院检验科，北京 100015
- Keywords:
Primary liver cancer;
Laboratory testing;
Diagnosis strategy
- From:
Chinese Journal of Preventive Medicine
2024;58(1):128-135
- CountryChina
- Language:Chinese
-
Abstract:
Primary liver cancer is one of the leading causes of cancer-related deaths worldwide, its early diagnosis and early treatment are of great clinical importance. The main detection tools for liver cancer include serological indicators, imaging tests and risk assessment models. With the advancement of technology and research, the sensitivity and specificity of laboratory tests for liver cancer have been substantially improved, but there are still false negatives and low rates of early diagnosis. For different causes and prevalence regions, each country has developed its clinical practice guidelines to guide risk groups for effective prevention, early diagnosis and standardized treatment. It is important to establish a liver cancer diagnosis strategy that is suitable for China′s national conditions, concerning the guidelines for the vigilance and prevention of liver cancer. In this article, the advantages and disadvantages of liver cancer-related tests and the impact of future development trends on laboratory strategies are explained from the perspective of laboratory testing strategies, to provide theoretical support for the practical application of liver cancer diagnostic strategies.
